← Evidence map

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells.

Dimpy Koul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

95 papers cite itlatest 60 shown

2012
…
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 22065080